Home
overview

SMi’s 9th Annual Conference
Biobanking
September 25-26, 2019 | London, United Kingdom
-------------------------------------------------------------------------
The event will bring together internationally recognised biorepositories, scientific pioneers from pharmaceutical companies, and academics to strengthen current knowledge in biosample management and their research applications. We will cover the most relevant hot topics including: the latest biorepository technological breakthroughs, the best practices in biobanking, shifts in the biosample regulation landscape, the international network of biobanks with BBMRI, ESBB and ISBER, successful biobanking business model structures and emerging biobank markets such as China.


With the estimated revenues of the global biobanking industry reaching US$ 27.54 billion in 2020, backed by an explosive CAGR of 9.5% between now and 2026. The biobanking market will likely see an influx of investors and innovation. Come join us in September 2019 and thoroughly understand the latest developments in the biobanking industry, network with industry experts, gain insight into how the biobanking industry at the forefront at driving precision medicine and enhancing research, discover the drone delivery of biosamples, discover the impact of the upcoming ISO, discover new opportunities. 


 

• Discuss latest shifts in the regulation landscape with the upcoming universal ISO and its impact on biobanks 

• Learn about the most successful biobanking business models using real case studies 
 

• Hear about the possibility of using drones to deliver biomaterial and other technological advances in biobanking
 

• Gain insight into global biobank collaboration network such as BBMRI, ESBB and ISBER and the international biobank market trends
 

Heads of Department, Directors, Managers, Team Leaders of:
 

Biobanks
Biorepositories
Biological Sample Management Centres
Genomic and Pharmacogenomic Research
Pathology Research Groups
Personalised Medicine and Translational Medicine Centres
Lab Management
Inventory Management
Molecular Technologies
Biologics Research
Data Privacy/Protection/Security Officers
Quality Control and Quality Management
Research and Development
Supply Chain and Cold Chain Distributors
Population-based Biobanks
Disease-based Biobanks
Hospital Trusts
Research Institutes
Technology Transfer Centres
Bio-innovation Centre
 

Ankara Yildirim Beyazit University; Auria Biobank; BioKryo GmbH; Biostor Ireland; Brooks Life Science Systems; BWB; Cambridge Blood and Stem Cell Biobank; European Commission; European Sperm Bank; Human Tissue Authority; Imperial College; Institute Of Child Health; Institute of Child Health University College London; Institute Of Food Research (I F R); Istanbul Medipol University; Karadeniz Technical University; King’s College London; Liconic; Liconic UK; LifelinesNL; London School of Hygiene & Tropical Medicine; Merck Research Laboratories; MRC CTU at UCL; National Institute For Biological Standards & Control; National Institute for Biological Standards and Control; Nottingham University Hospital NHS Trust; Regeneron Pharmaceuticals Inc; Scientist.com; The Faroese Biobank; Thermo Fisher Scientific; UCL; UCL Institute of Neurology; UK Biocentre; UKCRC Tissue Directory and Coordination Centre; University Hospital of South Manchester NHS Foundation Trust; University of Nottingham;
 

Conference programme

8:30 Registration & Coffee

9:00 Chairman's Opening Remarks

Laurent Dollé

Laurent Dollé, Operating Director, BWB (Biothéque Wallonie Bruxelles)
View Bio

9:10 FinnGen: how to effectively collect and maintain 100,000 patient samples and utilising biobank clinical data to drive precision medicine, with the fundamental concepts of biobanking

Dr. Kimmo Pitkänen

Dr. Kimmo Pitkänen, Director, Helsinki University Hospital; FinnGen
View Bio

• The Finnish network of hospital biobanks provides, based on patient consent, the majority of the patient samples to FinnGen. Helsinki Biobank is the largest hospital biobank in Finland, collecting samples from over 100 000 patients to FinnGen and with a pathology archive of samples from over 1M patients. However, the most important pillar of hospital biobanking is the clinical data in the hospital data lake. The talk will present both the Helsinki Biobank strategy and the work flows for the sample collection and clinical data analytics processes, as well as ongoing projects combining both.
• Outlining the biorepository process and learn how effective research translation will drive precision medicine
 

9:50 Biobanking: an R&D enabler for infectious disease diagnostics

Dr. Stefano Ongarello

Dr. Stefano Ongarello, Head of Data Services & Biobanking, Foundation for Innovative New Diagnostics (FIND)
View Bio

· Challenges and needs in the development of diagnostics for infectious diseases
· How to address developers needs while preserving patients’ rights
· Use of open source IT-systems for automated collection, inventory management and sample distribution
· Automated feedback and reporting on the use of samples
· Use of AI and big-data technologies for diagnostics development
 

10:30 Morning Coffee

11:00 A case study of BioBank AS, a biorepository focused on nonhuman biosamples

Dr. Sigbjorn Gregusson

Dr. Sigbjorn Gregusson, Managing Director, BioBank AS
View Bio

• Our definition of a biobank: BioBank AS as a tool for breeding animals, fish and plants
• Our market: BioBank's customer structure
• Our journey over the past 10 years: Development in livestock farming from phenotype to genomic selection
• Our challenges: Focus on core business and the value of cooperating partners
• Our success: Commercial operation, competence-intensive small-scale business
 

11:40 Regulatory hurdle to accessing biobanking for research, the implications, the workaround and possible improvements for regulators

Dr. Joanna Baxter

Dr. Joanna Baxter, Lead Scientist, Cambridge Blood and Stem Cell Biobank
View Bio

• Recognising the hurdles imposed by regulators to approval process, the work arounds and possible changes for regulators to streamline ethics applications. Joanna will also highlight the underestimation in legal counsel resource required by Universities and biobanks, many research projects could thrive if they are powered by sufficiently in ethics and regulatory affairs
• Why is transparency needed between biobanks through biosharing to prevent wastage of investigation resources
• Learn of the different biobanks business models with higher or lower upfront funding of biobanks and their long-term strategy and sustainability, which is more applicable to your biobank
 

12:20 Networking Lunch

13:50 Education and consciousness of end-users are key elements of the success stories of biobanks– Time for change with strategic thinking and End-users Outreach

Laurent Dollé

Laurent Dollé, Operating Director, BWB (Biothéque Wallonie Bruxelles)
View Bio

• Learn of ‘’Drone4Care’’ and how drones can be used for your biosamples delivery
• Detailing the cold-chain transport process, and describing the costs associated in maintaining desired quality of control by researchers
• Discovering novel bioprocessing technology, tissue microarray (TMA) that can can reduce number of biosamples needed from 200 down to 1
• Exploring ‘’Thinking outside the box’’ business strategies for biobanks to learn better cost recovery model for biobanks
 

14:30 The Medical Research Council UK Brain Bank Network: an invaluable research resource in the study of neurological conditions

• Case study introducing the central role of the Medical Research Council UK Brain Bank Network in the research community
• The application process including sample availability and linkage of biosample data
• Driving neurological research: The impact and scope of the MRC UK brain bank database
• RFTrackIT sample tracking system and cost recovery
 

Dr. Laura Palmer

Dr. Laura Palmer, Brain Bank Manager, UK Brain Bank Network
View Bio

Richard Cain

Richard Cain, Database Manager, UK Brain Bank Network
View Bio

15:10 Afternoon Tea

15:40 Human Pluripotent Stem Cells: Paving the way for clinical applications

Sofia Spyrou

Sofia Spyrou, Project Manager, UK Stem Cell Bank
View Bio

• Discovery the latest innovative concepts on Stem Cells Biobanking
• How important are stem cells quality controls
• Methods to personalising iPS Banking
• Banking of clinical grade human Pluripotent Stem Cells
 

16:20 Sustainable biobank cost recovery model case study: Duke University Medical Centre Biobank

Marybeth Joshi

Marybeth Joshi, Assistant Director, Duke University School of Medicine
View Bio

• Cost recovery model of Duke University Medical Centre Biobank: a biobank as a service point for scientific investigators, accepting and processing biosamples
• How to increase biosample data usage and collaboration by having referring sample level data to clinical data through multiple linkers
• Addressing the biobankers’ phenomenon of ‘This is the last sample.’
 

17:20 GDPR and the challenges in Biobanking

Kathrine Bancroft

Kathrine Bancroft, Legal Counsel, UK Biobank Limited
View Bio

• GDPR and the current landscape
• Anonymising data for research
• The approach of UK Biobank
 

18:40 Chairman's Closing Remarks and Close of Day One

Laurent Dollé

Laurent Dollé, Operating Director, BWB (Biothéque Wallonie Bruxelles)
View Bio

8:30 Registration & Coffee

9:00 Chairman's Opening Remarks

Dr. Jens K.Habermann

Dr. Jens K.Habermann, President, ESBB

9:10 The best practices for biobanking from collection, storage, distribution and biosamples utilisation

9:50 The ME/CFS Biobank, a biobank specialised by disease and the current development of the EUROMENE network

Dr. Eliana M Lacerda

Dr. Eliana M Lacerda, Clinical Assistant Professor - UKMEB Research Lead, London School Of Hygiene & Tropical Medicine
View Bio

• How to and why specialise a biobank by disease
• The current precision medicine development for neurological conditions fuelled by biosamples
• What is the EUROMENE network, what are their objectives and how to take part
• The challenges faced by ME/CFS Biobank and their solutions
 

10:30 Morning Coffee

11:00 Driving precision medicines for orphan disease by utilising the Eurobiobank

11:40 The Evolution of ISBER (The International Society of Biological and Environmental Repositories)

David Lewandowski

David Lewandowski, President, ISBER
View Bio

After 20 years, ISBER and their 4th Edition Best Practices continue to evolve and support the global approach to repository management. In this session, David will share highlights and global trends in biobanking. In addition, he will spend time discuss the new ISBER Best Practices, Cryogenic Storage Facility addendum done in conjunction with the Society for Cryobiology. This addendum was developed to support the research associated with the use of cells and other products reliant on storage temperatures below -135C (Tg).

12:20 Networking Lunch

13:50 How biobanks and strategic partnerships can empower biosharing, by supporting precision medicine: a Lübeck and ESBB perspective

Dr. Jens K.Habermann

Dr. Jens K.Habermann, ESBB President Head, Interdisciplinary Center for Biobanking-Lubeck, ESBB
View Bio

• Learn of the challenges and current solutions to resource sharing, data harmonization and standardisation
• What are the hurdles in IT infrastructure, GDPR and interconnectivity
• How to partner biobanks with researches to optimise precision medicines
• Understand the current developments of the national, international and global biobank networks and discovery the opportunities created
 

14:30 China Kadoorie Biobank case study: the sucesses and challenges in an operating a biobank across two contienients

15:10 Afternoon Tea

15:40 Increasing utilisation of Ukrainian biobanks by researchers to increase their significances

Dr. Gramatiuk Svetlana

Dr. Gramatiuk Svetlana , President and medical director Ukraine Association of Biobank, Ukraine Association of Biobank
View Bio

• Case study to learn how to drive collaborations between biobanks and researchers
• The challenges and successes for Ukraine Association of Biobank
• The business model adapted by the Ukrainian biobank at a national level
 

16:20 Challenges in sample standardisation for successful international biobank collaboration, how to drive precision medicine for cancer

Dr. Zisis Kozlakidis

Dr. Zisis Kozlakidis, Head, Laboratory Services and Biobanking, IARC/ WHO
View Bio

The regulation and bioethics complications between international borders and cross continents
• Current developments for oncology precision medicine due to IARC/WHO’s efforts
• How to increase partnerships of biobanks, academics and pharmaceutical companies world-wide to drive innovation
• The challenges faced by IARA Biobank and their solutions
 

17:00 GMP in biobanking, digitalization, standards, regulatory aspects, GDPR

17:40 Chairman's Closing Remarks and Close of Day Two

Dr. Jens K.Habermann

Dr. Jens K.Habermann, President, ESBB

+

FEATURED SPEAKERS

David Lewandowski

David Lewandowski

President, ISBER
Dr. Jens K.Habermann

Dr. Jens K.Habermann

President, ESBB
Dr. Kimmo Pitkänen

Dr. Kimmo Pitkänen

Director, Helsinki University Hospital; FinnGen
Dr. Zisis Kozlakidis

Dr. Zisis Kozlakidis

Head, Laboratory Services and Biobanking, IARC/ WHO
Laurent Dollé

Laurent Dollé

Operating Director, BWB (Biothéque Wallonie Bruxelles)

David Lewandowski

President, ISBER
David Lewandowski

David is the current President for the International Society of Biological and Environmental Repositories. He has contributed in various ways to ISBER during the past 10 years including as a Board Member and Committee Chair.
David’s brings over 20 years of experience in commercial and business development roles for various organizations in Life Sciences.   Over the last decade he has worked closely with Biorepository industry leaders from around the world who are implementing cryopreservation and storage strategies to minimize variability and improve documentation. Currently, he is a Global Product Marketing Manager at Brooks Life Sciences.
 

Dr. Eliana M Lacerda

Clinical Assistant Professor - UKMEB Research Lead, London School Of Hygiene & Tropical Medicine
Dr. Eliana M Lacerda

Dr Mattos Lacerda is a Clinical Assistant Professor at the London School of Hygiene & Tropical Medicine, co-founder of the UK Myalgic-Encephalomielytis/Chronic Fatigue Syndrome (ME/CFS) Biobank (UKMEB), and Vice-Chair of the EUROMENE (European ME/CFS Network). The UKMEB is a disease-specific bioresource, which was established to prompt high-quality biomedical research in the field, and which was nominated runner-up for the 2018 UK Biobank of the Year Award. EUROMENE brings together researchers and clinicians from over 20 countries in Europe, aiming to develop standards for research and health services for people with ME/CFS in the continent.
 

Dr. Gramatiuk Svetlana

President and medical director Ukraine Association of Biobank, Ukraine Association of Biobank
Dr. Gramatiuk Svetlana

Dr. Gramatiuk Svetlana she completed his PhD at the age of 27 years. She is the Medical Director Biobank from Ukraine Association. She has published more than 20 papers in reputed journals and also provide research area Science & Innovation Biobank in working group ESBB. She have a master’s degree in infectious diseases and she get master’s degree Biobank in Medical University Graz, Austria. The topic of my research was to study the Establishing a national biobank network in Ukraine.
In present time I continue to study Managements biobanks, and Stem cell researh of regenerative medicine.
 

Dr. Jens K.Habermann

President, ESBB
Dr. Jens K.Habermann

Dr. Jens K.Habermann

ESBB President Head, Interdisciplinary Center for Biobanking-Lubeck, ESBB
Dr. Jens K.Habermann

Professor Jens K. Habermann, M.D., PH.D., is Director of ICB-L (Interdisciplinary Center for Biobanking-Lübeck) and Scientific Director of UCCL (University Cancer Center Lübeck) at the University of Lübeck and University Clinic Schleswig-Holstein. He obtained his Ph.D. at the Karolinska Institutet (Stockholm, Sweden) and Postdoc training at the NCI, NIH (Bethesda, USA). As specialist in human genetics, he combines clinical routine, biobanking, and cancer research to optimize individualized medicine by targeting tumor heterogeneity and applying liquid biopsies. Prof. Habermann is President of ESBB (European, Middle Eastern & African Society for Biopreservation & Biobanking) and board member of GBA (German Biobank Alliance).
 

Dr. Joanna Baxter

Lead Scientist, Cambridge Blood and Stem Cell Biobank
Dr. Joanna Baxter

Joanna Baxter completed her PhD in 2003 from the University of Southampton, UK, studying rare chromosomal translocations and mutations in myeloid malignancies with Prof Nick Cross. Her postdoctoral studies included the discovery of the JAK2 mutation in MPNs in the lab of Prof Tony Green in Cambridge, before moving into her current role in 2009. She is the Lead Scientist and Custodian at Cambridge Blood and Stem Cell Biobank, a resource for research into Haematological malignancies, stem cells, normal haematopoiesis and immune developement, based on the Cambridge Biomedical Campus on the Addenbrookes Hospital site in Cambrdge. Alongside promoting biobanking in blood cancer research she is married with two young children.
 

Dr. Kimmo Pitkänen

Director, Helsinki University Hospital; FinnGen
Dr. Kimmo Pitkänen

Kimmo Pitkänen Ph.D Director of Helsinki Biobank. PhD from molecular biology of cancer. Experience from several expert positions at Academy of Finland, Tekes, European Commission DG Research, the Ministry of Social Affairs and Health and FIMM, University of Helsinki. Over 13 years of experience in ethical and legal questions of biobanking. Before joining Helsinki Biobank, he participated in the build-up and registration process of two disease specific biobanks (Helsinki Urological Biobank and Finnish Hematology Registry and Biobank FHRB).

Dr. Laura Palmer

Brain Bank Manager, UK Brain Bank Network
Dr. Laura Palmer

My biography is as follows: Dr Laura Palmer studied at the University of Bristol where she completed her degree in Pathology & Microbiology and later her PhD in Neuroscience. Laura joined the South West Dementia Brain (SWDBB) in 2004 as a research technician and now manages this important resource and its team. Whilst working in her SWDBBB role, Laura undertook a part-time PhD between 2006 and 2014 that was almost entirely conducted upon tissue from the SWDBB. Her research involved the Renin Angiotensin System (an important enzyme pathway and signalling system that acts to control blood pressure, fluid balance and hormone secretion) and Alzheimer's disease.
 

Dr. Sigbjorn Gregusson

Managing Director, BioBank AS
Dr. Sigbjorn Gregusson

Exam in Veterinary medicine: University of Veterinary Medicine Hanover, 1982
Veterinary Specialist in Public Health medicine: 1997->
Technical expert in Microbiology and Food Safety/ Assessor Accreditation bodies: 1986-2017

Clinical practitioner for several years included Public health and Meat control
Chief Hygiene officer of the Norwegian Army
Chief Veterinary officer of Municipal food control for more than one decade
Chief Executive Manager of a Norwegian laboratory company for another decade

Present: Executive Manager of BioBank AS (Ltd) in Hamar, Norway (2008 ->)

International missions in developing countries on Food safety and quality control and assessments for microbiological laboratories.

Experienced in Food safety and Public health.
Broad laboratory competence including management, logistics, LIMS, microbiology.
Biobank competence for animal repositories, biodata recording, breed and pedigree control
Management.
 

Dr. Stefano Ongarello

Head of Data Services & Biobanking, Foundation for Innovative New Diagnostics (FIND)
Dr. Stefano Ongarello

As Head of Data Services and Biobanking at FIND, Dr. Stefano Ongarello oversees the data-related activities of the organization, including data-driven decisions, statistical planning and analysis, data managing of clinical trials, and the operational aspects of the specimen bank.
In his previous roles, he worked for many years in the pharmaceutical industry in biomarker discovery, focusing on personalized medicine, mostly in oncology and rheumatology, and more recently on diagnostics for HIV.
Stefano graduated in Computer Science Engineering from the University of Padova, Italy, and later obtained his PhD in Bioengineering from the same university.
 

Dr. Zisis Kozlakidis

Head, Laboratory Services and Biobanking, IARC/ WHO
Dr. Zisis Kozlakidis

Dr Zisis Kozlakidis is the Head of Laboratories and Biobanking at the International Agency for Research on Cancer (IARC/WHO). He is responsible for one of the largest and most varied international collections of clinical samples in the world, focusing on gene–environment interactions and disease-based collections. This WHO infrastructure supports multinational efforts in making treatments possible and delivering those to resource-restricted settings.
 
Dr Kozlakidis is the immediate past President of ISBER, member of the BBMRI-ERIC Management Council and a Scientific Advisor at PTEN Foundation, UK. He holds faculty positions in China (Central South University), and the UK (Cass Business School).

Dr Kozlakidis is a virologist, with a PhD in microbiology from Imperial College London. He has extensive experience working with corporate industry, and has served as an advisor to healthcare start-ups. He is Fellow of the Linnean Society of London, the Royal Academy of Sciences, UK, and a Turnberg Fellow of the UK Academy of Medical Sciences.
 

Gramatiuk Svetlana

President and medical director Ukraine Association of Biobank, Ukraine Association of Biobank
Gramatiuk Svetlana

Kathrine Bancroft

Legal Counsel, UK Biobank Limited
Kathrine Bancroft

Kathrine Bancroft is a Legal Counsel at UK Biobank.  Kathrine joined the legal team of UK Biobank in 2014, having previously worked in private practice and in-house at a variety of commercial organisations.  Kathrine completed her LLB (Hons) at the University of Liverpool in 2001 and went on to train with international law firm Squire Patton Boggs where she qualified as a solicitor in 2005.  Kathrine is part of a team at UK Biobank who oversee the diverse legal and regulatory requirements of UK Biobank.  UK Biobank is one of the largest medical research resource in the world and is composed of data and samples for just over 500,000 UK participants who were recruited between 2007 and 2010. 
 

Laurent Dollé

Operating Director, BWB (Biothéque Wallonie Bruxelles)
Laurent Dollé

Laurent Dollé is a scientist in Biomedical Sciences with 16 years of
experience in Cell Biology and Molecular Biology with interests on
healthcare systems and innovative technologies/devises. Laurent
has a deep knowledge in the fild of breast cancer research (growth,
migration, invasion and metastasis), in hepatology (firosis, cirrhosis,
and hepatocarcinoma), and liver regeneration (stem cells, liver repair
and therapies, mouse models).
In 2012, Laurent became Assistant Professor at the Free University of
Brussels VUB, and from 2016, he became the operating manager of
the biobanks network from Wallonia-Brussels regions (BWB) allowing
him to accumulate a profound awareness on the vast ecosystem of
Biobanking (collection, harvesting, storage, distribution compliant with
international quality standards (GLP/GMP and ISO standards) and
regulations (law and royal decree). Since September 2017, Laurent is
the managing director at BWB.
 

Marybeth Joshi

Assistant Director, Duke University School of Medicine
Marybeth Joshi

For more than two decades Mary-Beth has been instrumental in the development, implementation, and management of biospecimen and clinical data repositories and associated experimental data within Duke University. Between 2010 and 2014, she assisted with the development and implementation of Duke’s first enterprise-wide biorespository (BioDuke). During this time she led the enterprise-wide standardized biobanking terminology project to unify clinical research biobanking informatics. In 2014, she partnered with the Department of Surgery to develop Substrate Services and Research Support Core (SSCRS). SSCRS serves as an integrated research support service to provide a standardized source for patient samples to be collected and clinically liked to biological profile. Mary-Beth now serves as the Director of SSCRS and as the Senior Director of BioDuke.
 

Richard Cain

Database Manager, UK Brain Bank Network
Richard Cain

Richard is a Microsoft certified software developer specialising in database technology and its applications for healthcare research.
He is currently the database developer and manager for the MRC brain banks network and “Brains for Dementia Research” and has developed the UKBBN database and web-application https://brainbanknetwork.cse.bris.ac.uk, which is a secure online tool allowing biobanks, researchers, and funders to manage and view data across 10 tissue-banks distributed through the UK.
 

Sofia Spyrou

Project Manager, UK Stem Cell Bank
Sofia Spyrou

Sofia Spyrou has over six years of experience as a production manager. She joined the UK Stem Cell Bank at NIBSC in 2016 and currently manages the day to day banking operations. Her focus is to review, bank and distribute the MRC funded “EUTCD-Grade” human embryonic stem cell lines. This requires following the Human Tissue Authority’s directions on meeting the EU Tissue and Cells Directive. Sofia is responsible for overseeing the complete UK Stem Cell Bank banking process which includes due diligence, banking under GMP conditions, validated QC testing and distributing lines to both national and international customers.   
 

Tony Burdett

Technical Team Leader, Archival Infrastructure and Technology, European Bioinformatics Institute (EMBL-EBI)
Tony Burdett

Tony Burdett leads the Archival Infrastructure and Technology team, developing services and delivering infrastructure to support the activities of EMBL-EBI’s molecular archives. He joined EMBL-EBI in 2005 and has personally built and led development teams for many resources such as the GWAS Catalog, ArrayExpress, the Expression Atlas and BioSamples. His team now develops the ingestion service for the Human Cell Atlas Data Coordination Platform.
Tony has a biological and medical background, having spent some time at medical school before graduating with a BSc in Biomedical Sciences and a MRes in Bioinformatics from the University of Newcastle-upon-Tyne. He has a special interest in developing federated, cloud-based data platforms and has many years of experience in developing semantically-rich RESTful APIs for the submission and distribution of life sciences data. He takes pride in his ability to marry profoundly complex biological problems with the very latest development techniques to create highly accomplished, open source, reusable software and services.

 

Veronique T'Joen

Biobank Manager, Ugent
Veronique T'Joen

VENUE

Copthorne Tara Hotel

Scarsdale Place, Kensington, London, United Kingdom

The Copthorne Tara Hotel London Kensington is an elegant contemporary four-star hotel in prestigious Kensington, located just a two minutes walk from High Street Kensington underground station, making exploring easy. The hotel offers well-appointed and comfortable guest rooms combining Standard, Superior and Club accommodation. Club rooms offer iconic views over the city and include Club Lounge access for complimentary breakfast and refreshments. Guests can sample the authentic Singaporean, Malaysian and Chinese cuisine at Bugis Street, traditional pub fare at the Brasserie Restaurant & Bar or relax with a delicious drink at West8 Cocktail Lounge & Bar.

The Copthorne Tara Hotel boasts 745 square meters of flexible meeting space, consisting of the Shannon Suite and the Liffey Suite, ideal for hosting conferences, weddings and social events. Facilities include access to the business centre 24 hours a day, fully equipped fitness room, gift shop, theatre desk and Bureau de Change. With ample onsite parking outside the London congestion charge zone and excellent transport links via Heathrow Airport, the hotel is the perfect location for business or leisure stays. The hotel is within close proximity to the shops of High Street Kensington, Knightsbridge and Westfield London, Olympia Conference Centre, Royal Albert Hall, Kensington Palace and Hyde Park.

 

HOTEL BOOKING FORM

SAVE TO


Outlook Calendar  OUTLOOK CALENDAR
Google Calendar  GOOGLE CALENDAR
ICal Calendar  ICAL CALENDAR
Yahoo! Calendar  YAHOO! CALENDAR

Copthorne Tara Hotel

Scarsdale Place
Kensington
London W8 5SR
United Kingdom

Copthorne Tara Hotel

The Copthorne Tara Hotel London Kensington is an elegant contemporary four-star hotel in prestigious Kensington, located just a two minutes walk from High Street Kensington underground station, making exploring easy. The hotel offers well-appointed and comfortable guest rooms combining Standard, Superior and Club accommodation. Club rooms offer iconic views over the city and include Club Lounge access for complimentary breakfast and refreshments. Guests can sample the authentic Singaporean, Malaysian and Chinese cuisine at Bugis Street, traditional pub fare at the Brasserie Restaurant & Bar or relax with a delicious drink at West8 Cocktail Lounge & Bar.

The Copthorne Tara Hotel boasts 745 square meters of flexible meeting space, consisting of the Shannon Suite and the Liffey Suite, ideal for hosting conferences, weddings and social events. Facilities include access to the business centre 24 hours a day, fully equipped fitness room, gift shop, theatre desk and Bureau de Change. With ample onsite parking outside the London congestion charge zone and excellent transport links via Heathrow Airport, the hotel is the perfect location for business or leisure stays. The hotel is within close proximity to the shops of High Street Kensington, Knightsbridge and Westfield London, Olympia Conference Centre, Royal Albert Hall, Kensington Palace and Hyde Park.

 

HOTEL BOOKING FORM

Title

SubTitle
speaker image

Content


Title


Description

Download


WHAT IS CPD?

CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

CPD AND PROFESSIONAL INSTITUTES

There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

As a formal provider of CPD certified activities, SMI Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

GLOBAL CPD

Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

CPD Certificates

We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@smi-online.co.uk

Event Title

Headline

Text
Read More

I would like to speak at an event

I would like to attend an event

I would like to sponsor/exhibit at an event

SIGN UP OR LOGIN

Sign up
Forgotten Password?

Contact SMi GROUP LTD

UK Office
Opening Hours: 9.00 - 17.30 (local time)
SMi Group Ltd, 1 Westminster Bridge Road, London, SE1 7XW, United Kingdom
Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
Website: http://www.smi-online.co.uk Email: events@smi-online.co.uk
Registered in England No: 3779287 VAT No: GB 976 2951 71




Forgotten Password

Please enter the email address you registered with. We will email you a new password.

Thank you for visiting our event

If you would like to receive further information about our events, please fill out the information below.

By ticking above you are consenting to receive information by email from SMi.
Full details of our privacy policy can be found here https://www.smi-online.co.uk/privacy-legals/privacy-policy/.
Should you wish to update your contact preferences at any time you can contact us at data@smi-online.co.uk.
Should you wish to be removed from any future mailing lists please click on the following link http://www.smi-online.co.uk/opt-out